All In Biotech

Free tool

FAERS Monitor: Prometrium

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020843 or its brand name (Prometrium, Progesterone). Reports on generic versions are filed under their own applications.

Reports

23,055

Serious

12,952

56% of reports

Hospitalization

3,658

Death reported

504

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache2,101
  • fatigue1,832
  • off label use1,831
  • drug ineffective1,821
  • nausea1,506
  • pain1,466
  • rash976
  • dizziness965
  • exposure during pregnancy925
  • foetal exposure during pregnancy921
  • hypersensitivity858
  • diarrhoea850
  • hyperhidrosis822
  • insomnia805
  • maternal exposure during pregnancy802

Reports by year received

View as table
YearReports
2004227
2005300
2006275
2007243
2008316
2009430
2010532
2011426
2012613
2013507
2014548
2015980
20161,372
20171,087
20181,152
20191,329
20201,386
20211,312
20221,480
20231,687
20242,061
20252,261
20262,531

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,104 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
exposure during pregnancySignal92513.812.910,808
foetal exposure during pregnancySignal92110.49.87,796
maternal exposure during pregnancySignal8028.37.75,098
hyperhidrosisSignal8225.95.53,302
hypersensitivitySignal8584.24.02,123
headacheSignal2,1013.12.92,999
insomniaSignal8052.82.6912
painSignal1,4662.22.1961
fatigueSignal1,8322.12.11,165
rashSignal9762.01.9530
off label use1,8311.91.8825
dizziness9651.81.7327
nausea1,5061.71.7488
drug ineffective1,8211.31.2104
diarrhoea8501.21.129

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.